Priti Sinha
- Assistant Professor, Psychiatry - (Clinical Scholar Track)
- Clinical Instructor, Pharmacy Practice-Science
- Assistant Clinical Professor, Psychiatry - (Clinical Series Track)
Contact
Degrees
- M.D.
- University of Illinois College of Medicine at Rockford, Rockford, Illinois, United States
Work Experience
- SAVAHCS (2011 - Ongoing)
- University Physician Hospital (currently South Campus) (2008 - 2011)
Awards
- Chief's Teacher of the Year for 2014-2015
- SAVAHCS, Summer 2015
Licensure & Certification
- Board certified in Pyschiatry and Neurology, ABPN (2010)
- Board Certified in Psychiatry and Neurology, ABPN (2020)
Interests
Teaching
Psychopharmacology and Telepsychiatry
Courses
No activities entered.
Scholarly Contributions
Journals/Publications
- Davis, M. F., Freeman, M. P., Gelenberg, A. J., Hibbeln, J. R., Sinha, P., & Wisner, K. L. (2008). Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study.. Journal of affective disorders, 110(1-2), 142-8. doi:10.1016/j.jad.2007.12.228More infoPerinatal major depressive disorder (MDD), including antenatal and postpartum depression, is common and has serious consequences. This study was designed to investigate the feasibility, safety, and efficacy of omega-3 fatty acids for perinatal depression in addition to supportive psychotherapy..Perinatal women with MDD were randomized to eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), 1.9g/day, or placebo for 8weeks. A manualized supportive psychotherapy was provided to all subjects. Symptoms were assessed with the Hamilton Rating Scale for Depression (HAM-D) and Edinburgh Postnatal Depression Scale (EPDS) biweekly..Fifty-nine women enrolled; N = 51 had two data collection points that allowed for evaluation of efficacy. Omega-3 fatty acids were well tolerated. Participants in both groups experienced significant decreases in EPDS and HAM-D scores (p
- Sinha, P., & Freeman, M. P. (2007). Tolerability of omega-3 fatty acid supplements in perinatal women.. Prostaglandins, leukotrienes, and essential fatty acids, 77(3-4), 203-8. doi:10.1016/j.plefa.2007.09.004More infoBenefits of omega-3 fatty acids in perinatal women are well documented, although fish intake has declined among perinatal women..To determine the tolerability of omega-3 fatty acid supplementation in perinatal women..Pregnant and postpartum women with major depressive disorder (MDD) entered an 8-week double-blind, placebo-controlled trial of omega-3 fatty acids. Four capsules provided 1.84 g/day of eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), or matching placebo (corn oil with 1% fish oil to maintain blind). Tolerability was assessed by clinician interview biweekly..Fifty-nine women enrolled. Thirteen (22%) reported mainly transient side effects including dizziness, diarrhea, nausea, burping, heartburn/reflux, difficulty swallowing capsules, unpleasant breath/bad taste or feeling tired. The most common were unpleasant breath/bad taste and heartburn/reflux. Six reporting side effects received omega-3 fatty acids; seven received placebo. Neither pregnant nor postpartum women discontinued due to intolerability..Omega-3 fatty acid supplements were well tolerated by perinatal women.
